Bicnu™
Active ingredients: Carmustine
Consumer medicine information
Read the CMI leaflet (Opens in new tab) for facts you need to know before, during and after taking your medicine.
For more information about CMIs and how to read them, please visit How to read Consumer Medicine Information (CMI).
What this medicine is used for
INDICATIONS AS AT 16 DECEMBER 1985: Carmustine is indicated as palliative therapy as a single agent or in established combination therapy with other approved chemotherapeutic agents in the following: 1. Malignant Glioma. 2. Multiple Myeloma: In combination with prednisone. 3. Hodgkin's Disease: As secondary therapy in combination with other approved drugs in patients who relapse while being treated with primary therapy, or who fail to respond to primary therapy. 4. Non-Hodgkins lymphomas: As secondary therapy in combination with other approved drugs for patients who relapse while being treated with primary therapy or who fail to respond to primary therapy.
Source: ARTG
Storage conditions
- Shelf lifetime is 36 Months
- Store at 2 to 8 degrees Celsius
- Do not Freeze; Refrigerate
Source: ARTG
How to use this medicine
Composite pack
This medicine is a pack that contains more than one component.
Important: The components listed below are not necessarily in order of use. Please refer to the Consumer Medicine Information (CMI) or consult your doctor for proper administration instructions and sequence.
Component
- Injection, powder for
- Intravenous
- Pale yellow powder
Component
- Diluent, not applicable
- Intravenous
- Clear colourless liquid
Source: ARTG
Do I need a prescription?
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4: Prescription Only Medicine.
- 1 vial of powder - 100mg each
- 10 vials of powders - 100mg each
Not scheduled medicines: We are unable to tell you if you need a prescription for these medicines. You can ask your pharmacist. These medicines are Not Scheduled.
- 1 vial of diluent - 3mL each
- 10 vials of diluent - 3mL each
Source: ARTG
Is this medicine subsidised?
This medicine is not listed on the Pharmaceutical Benefits Scheme (PBS). Talk to your pharmacist about how much it will cost.
Source: PBS
Pregnant or planning a pregnancy?
For the active ingredient: Carmustine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Source: AHT
Reporting side effects
If you experience a side effect from this medicine, tell your doctor or pharmacist. Or report it directly to the TGA (Therapeutic Goods Administration).
You can report side effects to your doctor, or directly at Report an adverse event or safety problem (Opens in new tab)
Source: ARTG
Data sources
- Australian Health Thesaurus (AHT) (Opens in new tab) – Last updated on 3 August 2026
- Australian Medicines Terminology (AMT) (Opens in new tab) – Last updated on 3 August 2026
- Australian Register of Therapeutic Goods (ARTG) (Opens in new tab) – Last updated on 3 August 2026
- Pharmaceutical Benefits Scheme (PBS) (Opens in new tab) – Last updated on 3 August 2026
- Medicines Information Pty Ltd (Opens in new tab) – Last updated on 4 March 2026
Disclaimer
Healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.
Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions (Opens in new tab).
Symptom Checker
Worried about your health?
Select a symptom, answer some questions, get advice